International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on May 27, 2025

Varonis at Infosecurity Europe 2025: Automating Data Security for the AI Era

Varonis at Infosecurity Europe 2025: Automating Data Security for the AI Era

MIAMI and LONDON, May 27, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its full event schedule for Infosecurity Europe 2025, taking place June 3 – 5 at ExCeL London. Varonis proudly returns to …

Arqit acquires Ampliphae’s technology IP, enhancing its global encryption portfolio

Arqit acquires Ampliphae’s technology IP, enhancing its global encryption portfolio

LONDON, May 27, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, today announced the acquisition of Ampliphae’s product portfolio IP and innovations team. The Ampliphae …

NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update

NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous …

Viral Coin Launches the First-Ever TikTok-to-Token Blockchain DApp on Solana

Viral Coin Launches the First-Ever TikTok-to-Token Blockchain DApp on Solana

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Viral Coin, the revolutionary new DApp built on Solana, has officially launched, becoming the first platform to directly link TikTok virality with on-chain token creation. With a simple comment and a tag to @ …

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

Research Triangle Park, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- AB-1005 was well tolerated with no attributed serious adverse events in participants with mild or moderate Parkinson’s disease (PD) through 18 months post-gene transfer Non-motor assessments …

HashFly Implements Advanced AI For Cloud Mining Operations

HashFly Implements Advanced AI For Cloud Mining Operations

New York City, NY, May 27, 2025 (GLOBE NEWSWIRE) -- HashFly, one of the leading cloud mining platform, is heading into the future with the integration of advanced artificial intelligence (AI) technology into its mining processes. With the use of AI, …

Leo International leaps from Lion City to Frankfurt with AI precision health listing

Leo International leaps from Lion City to Frankfurt with AI precision health listing

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG AG, a publicly listed company on the Frankfurt Stock Exchange (FSE). The company has now …

TruGolf Clarifies Nasdaq Compliance Plan and Provides Context to Equity Line of Credit

TruGolf Clarifies Nasdaq Compliance Plan and Provides Context to Equity Line of Credit

Salt Lake City, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, has clarified its plan to regain compliance with Nasdaq listing rules in response to shareholder inquiries. On August 19, 2024, …

Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting

Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting

ROCHESTER, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), …

AITX Releases Comprehensive Company Profile, Solidifying Solutions Leadership

AITX Releases Comprehensive Company Profile, Solidifying Solutions Leadership

New Resource Highlights AITX’s Solutions Portfolio, Operational Momentum, and Long-Term Vision Detroit, Michigan, May 27, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI- …

Hivello x Banxa - $HVLO Token Available via Apple Pay & Credit Card

Hivello x Banxa - $HVLO Token Available via Apple Pay & Credit Card

LONDON and AMSTERDAM, May 27, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle (computing) resources across multiple DePINs (Decentralized Physical Infrastructure Networks), announces that its native token …

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collaboration builds on …

Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease

Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease

Results shared during a R…

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

WILMINGTON, Del., May 27, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be presenting at the William Blair 45th Annual Growth Stock …

Zeo Energy Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

Zeo Energy Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

NEW PORT RICHEY, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today reported financial results for the …

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)

REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS), today announced a clinical collaboration with STORM Therapeutics, Ltd. (“STORM”) to evaluate STC-15, a METTL3 inhibitor, in combination with …

Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time

Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time

Overland Park, KS, May 27, 2025 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), today announced that it will host an investor conference call on Wednesday, May 28, 2025, at 11:15 a.m. Eastern time to discuss its operating results for …

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK)  No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs observed across SAD/MAD cohorts Management releases a “ …

SEALSQ Invests in Wecan Token to Advance Post-Quantum Digital Identity and Strengthen Blockchain Security, following a Strategic Partnership with SOLANA

SEALSQ Invests in Wecan Token to Advance Post-Quantum Digital Identity and Strengthen Blockchain Security, following a Strategic Partnership with SOLANA

Geneva, Switzerland, May 27, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a leader in Semiconductors, PKI, and Post-Quantum cybersecurity solutions, today announced a strategic investment in Wecan Token, reinforcing its …

NANO Nuclear Energy Announces Pricing of $105 Million Private Placement of Common Stock

NANO Nuclear Energy Announces Pricing of $105 Million Private Placement of Common Stock

The offering includes primary participation from fundamental institutional investors, including a leading long-only mutual fund and a preeminent global investment manager Company total cash position expected to be over $200 million following closing New …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service